SWOG
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1956-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.swog.org
SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil
- First Posted Date
- 2004-06-16
- Last Posted Date
- 2012-03-08
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 75
- Registration Number
- NCT00003254
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸CCOP - Dayton, Kettering, Ohio, United States
🇺🇸University of Texas Medical Branch, Galveston, Texas, United States
S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer
- Conditions
- Head and Neck Cancer
- Interventions
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- SWOG Cancer Research Network
- Registration Number
- NCT00084435
- Locations
- 🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States
🇺🇸Grant Riverside Cancer Services, Columbus, Ohio, United States
🇺🇸USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2012-11-01
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 242
- Registration Number
- NCT00085501
- Locations
- 🇺🇸
Sletten Regional Cancer Institute, Great Falls, Montana, United States
🇺🇸Gibbs Regional Cancer Center at Spartanburg Regional Medical Center, Spartanburg, South Carolina, United States
🇺🇸CCOP - Atlanta Regional, Atlanta, Georgia, United States
SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed
- Conditions
- Colorectal Cancer
- Interventions
- Radiation: radiation therapy
- First Posted Date
- 2004-06-10
- Last Posted Date
- 2013-04-05
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 1917
- Registration Number
- NCT00002551
- Locations
- 🇺🇸
CCOP - Marshfield Medical Research and Education Foundation, Marshfield, Wisconsin, United States
🇺🇸Hahnemann University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma
- Conditions
- Lymphoma
- Interventions
- Biological: bleomycin sulfateBiological: filgrastimDrug: trimethoprim-sulfamethoxazoleRadiation: radiation therapy
- First Posted Date
- 2004-05-24
- Last Posted Date
- 2013-01-24
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 52
- Registration Number
- NCT00002571
- Locations
- 🇺🇸
MBCCOP - University of South Alabama, Mobile, Alabama, United States
🇺🇸USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2004-05-21
- Last Posted Date
- 2013-04-18
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 68
- Registration Number
- NCT00003908
- Locations
- 🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States
🇺🇸MBCCOP - University of South Alabama, Mobile, Alabama, United States
🇺🇸Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States
S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2004-05-19
- Last Posted Date
- 2015-10-26
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 26
- Registration Number
- NCT00003095
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸Beckman Research Institute, City of Hope, Los Angeles, California, United States
S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
- First Posted Date
- 2004-04-26
- Last Posted Date
- 2015-11-17
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 58
- Registration Number
- NCT00005832
- Locations
- 🇺🇸
CCOP - Montana Cancer Consortium, Billings, Montana, United States
🇺🇸CCOP - Columbus, Columbus, Ohio, United States
🇺🇸CCOP - Upstate Carolina, Spartanburg, South Carolina, United States
S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Biological: filgrastimRadiation: radiation therapyProcedure: autologous bone marrow transplantationProcedure: peripheral blood stem cell transplantation
- First Posted Date
- 2004-04-22
- Last Posted Date
- 2013-01-24
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 602
- Registration Number
- NCT00002772
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2004-04-22
- Last Posted Date
- 2013-01-03
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 54
- Registration Number
- NCT00003018
- Locations
- 🇺🇸
MBCCOP - University of South Alabama, Mobile, Alabama, United States
🇺🇸Loyola University Medical Center, Maywood, Illinois, United States
🇺🇸USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States